345 related articles for article (PubMed ID: 15036680)
1. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
Montorsi F; Verheyden B; Meuleman E; Jünemann KP; Moncada I; Valiquette L; Casabé A; Pacheco C; Denne J; Knight J; Segal S; Watkins VS
Eur Urol; 2004 Mar; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
[TBL] [Abstract][Full Text] [Related]
4. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
Kloner RA; Jackson G; Hutter AM; Mittleman MA; Chan M; Warner MR; Costigan TM; Vail GM
Am J Cardiol; 2006 Jun; 97(12):1778-84. PubMed ID: 16765134
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
Yip WC; Chiang HS; Mendoza JB; Tan HM; Li MK; Wang WC; Kopernicky V
Asian J Androl; 2006 Nov; 8(6):685-92. PubMed ID: 16855765
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
Hatzichristou D; Gambla M; Rubio-Aurioles E; Buvat J; Brock GB; Spera G; Rose L; Lording D; Liang S
Diabet Med; 2008 Feb; 25(2):138-46. PubMed ID: 18290855
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
Segraves RT; Lee J; Stevenson R; Walker DJ; Wang WC; Dickson RA
J Clin Psychopharmacol; 2007 Feb; 27(1):62-6. PubMed ID: 17224715
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
14. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men.
McMahon CG; Stuckey BG; Lording DW; Wittert GA; Murphy A; Shin J; Sutherland PD; Palmer NR; Lowy MP; Jesudason DR; Fredlund P
Int J Clin Pract; 2005 Feb; 59(2):143-9. PubMed ID: 15854188
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
Incrocci L; Slagter C; Slob AK; Hop WC
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):439-44. PubMed ID: 16965992
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
Hellstrom WJ; Gittelman M; Jarow J; Steidle C; McMurray J; Talley D; Watts S; Mitchell CL; McGill JM
Eur Urol; 2008 May; 53(5):1058-65. PubMed ID: 17945409
[TBL] [Abstract][Full Text] [Related]
18. Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction.
Brock G; Glina S; Moncada I; Watts S; Xu L; Wolka A; Kopernicky V
Urology; 2009 Apr; 73(4):756-61. PubMed ID: 19193420
[TBL] [Abstract][Full Text] [Related]
19. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study.
Fugl-Meyer KS; Stothard D; Belger M; Toll A; Berglund O; Eliasson T; Fugl-Meyer AR
Int J Clin Pract; 2006 Nov; 60(11):1386-93. PubMed ID: 17073836
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of tadalafil: an update.
Carson CC; Rajfer J; Eardley I; Carrier S; Denne JS; Walker DJ; Shen W; Cordell WH
BJU Int; 2004 Jun; 93(9):1276-81. PubMed ID: 15180622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
